17 news items
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
LLY
23 May 24
Securities Litigation Reform Act of 1995) about Verzenio® (abemaciclib) as a potential treatment
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
LLY
21 May 24
release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about mirikizumab
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
ABBV
JNJ
LLY
21 May 24
and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
ELAB
LLY
NVO
17 May 24
statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "believes," "expects
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
LLY
16 May 24
release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about insulin efsitora alfa
snkbapj93omfusw5mmk4wf
ABBV
ATNM
AZN
8 May 24
and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward
z9thszqm374ha111mmg68ua uihhnw
LLY
6 May 24
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about
t3d051qpkh2c2fblm2vz8d1ylu vry2pdcoke
ABBV
FIX
JNJ
3 May 24
litigation, has proposed a "Plan of Reorganization" to resolve all present and future pending ovarian cancer talc lawsuits
J
jpzq0sv46lndztut0o1p0oon ogxa9jyzl94m4s2wimptfhdvj
LLY
30 Apr 24
, litigation, cybersecurity, and other risks; the impact of global macroeconomic conditions, including uneven economic growth or downturns or uncertainty
y9i6nlsxgdf25dlcxgs3015je1n4xyjc
ABBV
ATNM
AZN
22 Apr 24
advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement
dbsc2wbirrwepj8otan89hfiy912va8nbwjg3pd1ycv51h9w8uasiwgd
ABBV
ATNM
AZN
19 Apr 24
not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking
yeppa4w9
ATNM
AZN
BMY
18 Apr 24
Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects
y9ekdm3vgc1n1dlh5
LLY
17 Apr 24
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform
mj4 b32ylle
LLY
NVO
NVS
22 Mar 24
in Philadelphia.
Meanwhile, more litigants are considering joining the legal battle as attorneys await guidance from the court
2y871hygazs8
LLY
10 Mar 24
Litigation Reform Act of 1995) about lebrikizumab as a treatment for people with moderate-to-severe atopic dermatitis and reflects Lilly's current
s030opi7cnyd9aysgukuszu3dy973afzpgmcxqjosa2ytjag3x7w
LLY
8 Mar 24
-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about donanemab as a potential treatment
ae8xtjx3x3ajpex24te9u3gqykbg8es7gndf7h0f e3lw2
LLY
5 Mar 24
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform
- Prev
- 1
- Next